## HIMS: Hims & Hers Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -0.9% below STRENGTH zone (4.0-10.0%); PEG 5.23 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($32.97)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. (HIMS) Movement as an Input in Quant Signal Sets**
- Source: Stock Traders Daily | 20251209T215800 | Bullish | Relevance: 98%
- This article from Stock Traders Daily discusses Hims & Hers Health Inc. (NASDAQ: HIMS), highlighting strong sentiment across all time horizons supporting an overweight bias. It presents specific AI-generated trading strategies for HIMS, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The analysis also points to an exceptional 112.6:1 risk-reward setup.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $48 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.57M) |
| Sells | 25 ($13.26M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 67.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- JPMORGAN CHASE & CO: 16.2% (+1198.1%)
- Blackrock Inc.: 11.5% (+1.6%)
- Vanguard Group Inc: 8.9% (+4.5%)
- Capital World Invest: 8.6% (+1.2%)
- Farallon Capital Man: 4.9% (+30.8%)

### Key Risks

1. High beta (2.41) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $13M sold (25 transactions in 90 days).
3. Valuation risk: PEG 5.2x with declining EPS estimates leaves no margin for error.
4. High short interest (36.6%, 2.6 days to cover): squeeze risk or crowded bearish bet.
5. Long-term trend broken: trading 17.7% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.23 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Insider selling cluster ($13.3M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.6B |
| Beta | 2.41 |
| 52W Range | $23.97 - $72.98 |
| Short Interest | 36.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.23 |
| Forward P/E | 57.4 |
| Current P/E | 79.1 |
| YoY Growth | 37.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 1.8% to -0.9% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.0pp (needs >4.0% for momentum thesis). Below SMA200 (0.82x), long-term trend not supportive. MACD histogram positive (0.62), confirming momentum. RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.95% (CS: 39) | Neutral |
| RSI_14 | 44.1 | Neutral |
| MACD Histogram | 0.62 | Bullish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 0.847x | Below |
| vs SMA200 | 0.823x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $37.77
- **Stop Loss:** $32.97 (12.7% risk)
- **Target:** $42.57 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 287
- **Position Value:** $10,839.99
- **Portfolio %:** 10.84%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-23 (Est: $0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.10 | $0.06 | -41.0% |
| 2025Q2 | $0.16 | $0.17 | +3.2% |
| 2025Q1 | $0.12 | $0.20 | +65.0% |
| 2024Q4 | $0.11 | $0.11 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*